focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Share News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK shareholder meetings calendar - next 7 days

Mon, 25th Oct 2021 16:03

Tuesday 26 October 
Dispersion Holdings PLCGM re share allotment
Wednesday 27 October 
Cap-XX LtdAGM
Frontier Developments PLCAGM
Hargreaves Services PLCAGM
Ideagen PLCAGM
Investment Co PLCAGM
Invinity Energy Systems PLCAGM
JPMorgan Global Growth & Income PLCAGM
Mirada PLCAGM
Pantheon International PLCAGM
Puma VCT 11 PLCGM re winding up
Springfield Properties PLCAGM
Thursday 28 October 
Brooks Macdonald Group PLCAGM
City of London Investment Trust PLCAGM
Filtronic PLCAGM
Highbridge Tactical Credit Fund LtdAGM
JD Sports Fashion PLCGM re proposed share sub-division
National Milk Records PLCAGM
South32 LtdAGM
Tirupati Graphite PLCAGM
Tirupati Graphite PLCGM re acquisition, warrants
Friday 29 October 
ADM Energy PLCAGM
Adriatic Metals PLCGM re funding package for Vares silver project
ITM Power PLCAGM
Mattioli Woods PLCAGM
MaxCyte PLCAGM
OPG Power Ventures PLCAGM
Sensyne Health PLCAGM
Monday 1 November 
Capital & Regional PLCGM re capital raising
Electra Private Equity PLCGM re Hostmore demerger
French Connection Group PLCGM re takeover by MIP Holdings
Silence Therapeutics PLCGM re cancellation of admission to trading
Vietnam Holding LtdAGM
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
1 Jul 2021 17:05

EXECUTIVE CHANGES: AB Dynamics founder retires; Resolute hires CFO

EXECUTIVE CHANGES: AB Dynamics founder retires; Resolute hires CFO

Read more
8 Jun 2021 16:03

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
7 Jun 2021 08:51

Silence Therapeutics to present positive data from 'SLN124'

(Sharecast News) - Silence Therapeutics announced on Monday that it would present data showing the potential for 'SLN124' to address a range of hematological diseases by targeting the liver-expressed gene TMPRSS6.

Read more
2 Jun 2021 16:02

EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus

EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus

Read more
25 May 2021 19:40

TRADING UPDATES: Bank of Cyprus outlook hinges on tourism industry

TRADING UPDATES: Bank of Cyprus outlook hinges on tourism industry

Read more
25 May 2021 12:35

Silence Therapeutics receives remaining $40m from AstraZeneca partnership

(Sharecast News) - Silence Therapeutics announced receipt of the remaining $40m (£28.24m) from AstraZeneca on Tuesday, due as part of AstraZeneca's $80m cash and equity investment for the siRNA collaboration announced in March 2020.

Read more
19 May 2021 19:33

TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment

TRADING UPDATES: Young's mulls asset sale; Ceres gets China investment

Read more
19 May 2021 10:20

Silence Therapeutics reveals positive data from SLN124 study

(Sharecast News) - Silence Therapeutics announced positive topline data from the 'GEMINI' phase 1 study of its wholly-owned product candidate 'SLN124' in healthy volunteers on Wednesday.

Read more
29 Apr 2021 14:34

TRADING UPDATES: STV looks to summer's football; In The Style sales up

TRADING UPDATES: STV looks to summer's football; In The Style sales up

Read more
29 Apr 2021 09:48

Silence Therapeutics doses first patient in 'GEMINI II' study

(Sharecast News) - Silence Therapeutics announced on Thursday that the first patient has been dosed in the 'GEMINI II' phase 1 clinical study of its wholly-owned lead product candidate, SLN124, for the treatment of 'iron-loading' anemias, thalassemia and myelodysplastic syndrome (MDS).

Read more
28 Apr 2021 19:20

IN BRIEF: Silence Therapeutics achieves further Mallinckrodt milestone

IN BRIEF: Silence Therapeutics achieves further Mallinckrodt milestone

Read more
28 Apr 2021 13:33

Silence Therapeutics gets $2m milestone payment from Mallinckrodt

(Sharecast News) - Silence Therapeutics has achieved another research milestone as part of its ongoing RNAi collaboration with Mallinckrodt for complement-mediated diseases, it announced on Wednesday, triggering a further $2m payment.

Read more
19 Apr 2021 14:58

DIRECTOR DEALINGS: Silence Therapeutics top team buy USD540,000 worth

DIRECTOR DEALINGS: Silence Therapeutics top team buy USD540,000 worth

Read more
30 Mar 2021 20:33

TRADING UPDATES: Numis expects interim revenue rise; Dods profit swing

TRADING UPDATES: Numis expects interim revenue rise; Dods profit swing

Read more
23 Mar 2021 16:07

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.